DNA microarray technology and its applications in dermatology

Experimental Dermatology

Volumn 13, Issue 10, 2004, Pages 593-606

  Kunz, Manfred ^a   Ibrahim, S M ^a   Koczan, D ^a   Scheid, S ^b   Thiesen, H J ^a   Gross, G ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Microarray; mRNA expression profiles; RNA interference; Single nucleotide polymorphisms

Indexed keywords

COMPLEMENTARY DNA; OLIGONUCLEOTIDE;

BIOINFORMATICS; BIOSTATISTICS; CARCINOGENESIS; DERMATOLOGY; DISEASE PREDISPOSITION; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCUS; GENE TARGETING; GENETIC MARKER; GENOMICS; HUMAN; LASER CAPTURE MICRODISSECTION; LUPUS ERYTHEMATOSUS; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; MELANOMA; NONHUMAN; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PSORIASIS; REVIEW; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN INFLAMMATION; ULTRAVIOLET RADIATION;

CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; HUMANS; HYBRIDIZATION, GENETIC; KERATINOCYTES; KERATINS; MELANOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PSORIASIS; RNA, MESSENGER; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 5144234920     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0906-6705.2004.00243.x     Document Type: Review

References (83)

1. Anonymous. To ... affinity and beyond. Nat Genet 1996: 14: 367-370.
2. Fodor S P, Read J L, Pirrung M C, Stryer L, Lu A T, Solas D. Light-directed, spatially addressable parallel chemical synthesis. Science 1991: 251: 767-773.
3. Southern E M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975: 98: 503-517.
4. Southern E, Mir K, Shchepinov M. Molecular interactions on microarrays. Nat Genet 1999: 21: 5-9.
5. Lockhart D J, Dong H, Byrne M C, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996: 14: 1675-1680.
6. Duggan D J, Bittner M, Chen Y, Meltzer P, Trent J M. Expression profiling using cDNA microarrays. Nat Genet 1999: 21 (Suppl.): 10-14.
7. Cheung V G, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G. Making and reading microarrays. Nat Genet 1999: 21 (Suppl.): 15-19.
8. Chee M, Yang R, Hubbell E, et al. Accessing genetic information with high-density DNA arrays. Science 1996:274:610-614.
9. Hacia J G, Brody L C, Chee M S, Fodor S P, Collins F S. Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat Genet 1996: 14: 441-447.
10. Wen W H, Bernstein L, Lescallett J, et al. Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. Cancer Res 2000: 60: 2716-2722.
11. Lander E S. The new genomics: global views of biology. Science 1996: 274: 536-539.
12. Shastry B S. SNP alleles in human disease and evolution. J Hum Genet 2002: 47: 561-566.
13. Naef F, Lim D A, Patil N, Magnasco M. DNA hybridization to mismatched templates: a chip study. Phys Rev E 2002: 65: 040902(R).
14. Irizarry R A, Bolstad B M, Collin F, Cope L M, Hobbs B, Speed T P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003: 31 (4): e15.
15. Schuler G D, Boguski M S, Stewart E A, et al. A gene map of the human genome. Science 1996: 274: 540-546.
16. Liang P, Pardee A B. Analysing differential gene expression in cancer. Nat Rev Cancer 2003: 3: 869-876.
17. Lander E S. Array of hope. Nat Genet 1999: 21 (Suppl.): 3-4.
18. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002: 32 (Suppl.): 496-501.
19. Draghici S. Statistical intelligence: effective analysis of high-density microarray data. Drug Discov Today 2002: 7 (11 Suppl.): S55-S63.
20. Huber W, von Heydebreck A, Sültmann H, Poustka A, Vingron M. Variance stabilization applied to micro-array data calibration and to the quantification of differential expression. Bioinformatics 2002: 18 (Suppl. 1): S96-S104.
21. Bolstad B M, Irizarry R A, Astrand M, Speed T P. A comparison of normalization for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003: 19: 185-193.
22. Yang Y H, Dudoit S, Luu P, et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002: 30: e15.
23. Efron B, Tibshirani R, Storey J D, Tusher V. Empirical Bayes analysis of a microarray experiment. J Am Stat Assoc 2001: 456: 1151-1160.
24. Westfall P H, Young S S. Resampling-Based Multiple Testing: Examples and Methods for P-Value Adjustment. John Wiley & Sons New York, 1993.
25. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 1995: 57: 289-300.
26. Dudoit S, Shaffer J P, Boldrick J C. Multiple hypothesis testing in microarray experiments. U.C. Berkeley Division of Biostatistics Working Paper Series, 2002: 110.
27. Storey J D, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA 2003: 100:9440-9445.
28. Tusher V G, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001: 98: 5116-5121.
29. Brown M P, Grundy W N, Lin D, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci USA 2000: 97: 262-267.
30. Bishop C M. Neural Networks for Pattern Recognition. Oxford University Press New York, 1995.
31. Kaufman L, Rousseeuw P J. Finding Groups in Data. An Introduction to Cluster Analysis. John Wiley & Sons New York, 1990.
32. Eisen M B, Spellman P T, Brown P O, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998: 95: 14863-14868.
33. Getz G, Levine E, Domany E. Coupled two-way clustering analysis of gene microarray data. Proc Natl Acad Sci USA 2000: 97: 12079-12084.
34. Scherf U, Ross D T, Waltham M, et al. A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000: 24: 236-244.
35. Alizadeh A A, Eisen M B, Davis R E, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000: 403: 503-511.
36. Ramaswamy S, Ross K N, Lander E S, Golub T R. A molecular signature of metastasis in primary solid tumors. Nat Genet 2003: 33: 49-54.
37. Kohonen T. Comparison of SOM point densities based on different criteria. Neural Comput 1999: 11: 2081-2095.
38. Dopazo J, Zanders E, Dragoni I, Amphlett G, Falciani F. Methods and approaches in the analysis of gene expression data. J Immunol Methods 2001: 250: 93-112.
39. Pan W. A comparative review of statistical methods for discovering differentially expressed genes in replicated microarray experiments. Bioinformatics 2002: 18: 546-554.
40. Liotta L, Petricoin E. Molecular profiling of human cancer. Nat Rev Genet 2000: 1: 48-56.
41. Ramaswamy S, Golub T R. DNA microarrays in clinical oncology. J Clin Oncol 2002: 20: 1932-1941.
42. DeRisi J, Penland L, Brown P O, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996: 14: 457-460.
43. Nesbit M, Schaider H, Miller T H, Herlyn M. Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in non-tumorigenic melanoma cells. J Immunol 2001: 166: 6483-6490.
44. Fang D, Tsuji Y, Setaluri V. Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Res 2002: 30: 3096-3106.
45. Clark E A, Golub T R, Lander E S, Hynes R O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 2000: 406: 532-535.
46. Gruss C, Herlyn M. Role of cadherins and matrixins in melanoma. Curr Opin Oncol 2001: 13: 117-123.
47. Kunz M, Koczan D, Ibrahim S, Gillitzer R, Gross G, Thiesen H J. Differential expression of thrombospondin 2 in primary and metastatic malignant melanoma. Acta Derm Venereol 2002: 82: 163-169.
48. Bittner M, Meltzer P, Chen Y, et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000: 406: 536-540.
49. Folberg R, Hendrix M J, Maniotis A J. Vasculogenic mimicry and tumor angiogenesis. Am J Pathol 2000: 156: 361-381.
50. Carr K M, Bittner M, Trent J M. Gene-expression profiling in human cutaneous melanoma. Oncogene 2003: 22: 3076-3080.
51. Gutgemann A, Golob M, Müllers, Buettner R, Bosserhoff A K. Isolation of invasion-associated cDNAs in melanoma. Arch Dermatol Res 2001: 293: 283-290.
52. Leethanakul C, Patel V, Gillespie J, et al. Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 2000: 19:3220-3224.
53. Kunz M, Moeller S, Koczan D, et al. Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem 2003: 278: 45651-45660.
54. Harris A L. Hypoxia - a key regulatory factor in tumor growth. Nat Rev Cancer 2002: 2: 38-47.
55. Straume O, Akslen L A. Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression. Am J Pathol 2002: 160: 1009-1019.
56. Tsai M S, Bogart D F, Castaneda J M, Li P, Lupu R. Cyr61 promotes breast tumorigenesis and cancer progression. Oncogene 2002: 21: 8178-8185.
57. Becker B, Roesch A, Hafner C, et al. Discrimination of melanocytic tumors by cDNA array hybridization of tissues prepared by laser pressure catapulting. J Invest Dermatol 2004: 122: 361-368.
58. Van 't Veer L J, Dai H, van de Vijver M J, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002: 415: 530-536.
59. Bowcock A M, Shannon W, Du F, et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001: 10: 1793-1805.
60. Oestreicher J L, Walters I B, Kikuchi T, et al. Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 2001: 1: 272-287.
61. Zhou X, Krueger J G, Kao M C, et al. Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 2003: 13: 69-78.
62. Maas K, Chan S, Parker J, et al. Cutting edge: molecular portrait of human autoimmune disease. J Immunol 2002: 169: 5-9.
63. Gu J, Marker-Hermann E, Baeten D, et al. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. Rheumatology (Oxford) 2002: 41: 759-766.
64. Rosen A, Casciola-Rosen L. Clearing the way to mechanisms of autoimmunity. Nat Med 2001: 7: 664-665.
65. Becker B, Vogt T, Landthaler M, Stolz W. Detection of differentially regulated genes in keratinocytes by cDNA array hybridization: Hsp27 and other novel players in response to artificial ultraviolet radiation. J Invest Dermatol 2001: 116: 983-988.
66. Galvin S, Loomis C, Manabe M, Dhouailly D, Sun T T. The major pathways of keratinocyte differentiation as defined by keratin expression: an overview. Adv Dermatol 1989: 4: 277-299.
67. Bonner R F, Emmert-Buck M, Cole K, et al. Laser capture microdissection: molecular analysis of tissue. Science 1997: 278: 1481-1483.
68. Mikulowska-Mennis A, Taylor T B, Vishnu P, et al. High-quality RNA from cells isolated by laser capture microdissection. Biotechniques 2002: 33: 176-179.
69. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, et al. Expression profiling of microdissected pancreatic adenocarcinomas. Oncogene 2002: 21: 4587-4594.
70. Fink L, Kohlhoff S, Stein M M, et al. cDNA array hybridization after laser-assisted microdissection from nonneoplastic tissue. Am J Pathol 2002: 160: 81-90.
71. Specht K, Richter T, Müller U, Walch A, Werner M, Hofler H. Quantitative gene expression analysis in micro-dissected archival formalin-fixed and paraffin-embedded tumor tissue. Am J Pathol 2001: 158: 419-429.
72. Roses A D. Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov 2002: 1: 541-549.
73. Lipshutz R J, Fodor S P, Gingeras T R, Lockhart D J. High density synthetic oligonucleotide arrays. Nat Genet 1999: 21 (1 Suppl.): 20-24.
74. Hacia J G, Fan J B, Ryder O, et al. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 1999: 22: 164-167.
75. Lindblad-Toh K, Tanenbaum D M, Daly M J, et al. Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 2000: 18: 1001-1005.
76. Mei R, Galipeau P C, Prass C, et al. Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 2000: 10: 1126-1137.
77. Kristensen V N, Harada N, Yoshimura N, et al. Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 2000: 19: 1329-1333.
78. Harada H, Nagai H, Tsuneizumi M, Mikami I, Sugano S, Emi M. Identification of DMC1, a novel gene in the TOC region on 17q25.1 that shows loss of expression in multiple human cancers. J Hum Genet 2001:46:90-95.
79. Noll W W, Belloni D R, Rutter J L, et al. Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloprotemase-1 promoter. Am J Pathol 2001: 158: 691-697.
80. Milhavet O, Gary D S, Mattson M P. RNA interference in biology and medicine. Pharmacol Rev 2003: 55: 629-648.
81. Paddison P J, Caudy A A, Bernstein E, Bernstein E, Hannon G J, Conklin D S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002: 16: 948-958.
82. Calegari F, Haubensak W, Yang D, Huttner W B, Buchholz F. Tissue-specific RNA interference in post-implantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc Natl Acad Sci USA 2002: 99: 14236-14240.
83. Lewis B P, Shih I H, Jones-Rhoades M W, Bartel D P, Burge C B. Prediction of mammalian microRNA targets. Cell 2003: 115: 787-798.